We dosed the first patient in our Phase 1 REPLACE trial evaluating RNDP-001, a neuron replacement cell therapy for idiopathic #ParkinsonsDisease. RNDP-001 also received #FDA #FastTrackDesignation. Learn more: bit.ly/4qdLUe0

Q3 Clinical trials round-up: July to September 2025 As the third quarter of 2025 draws to a close, the clinical research landscape has been marked by a surge of promising data and regulatory milestones.

#drugdevelopment #Clinicaltrials #RandD #clinicalresearch #neurodegeneration #regenerativemedicine #clinicaltrialdevelopments #orphandrugdesignation #preclinicaldata #fasttrackdesignation #expandedaccess #FDApriorityreview #clinicalprogress #strategicfunding
zurl.co/jmZiW

Umoja's in vivo cell therapy fast-tracked by FDA A pioneer of in vivo cell therapy, Umoja has cleared another regulatory milestone by getting fast-track status for its lead blood cancer programme.

One of the pioneers of in vivo #celltherapy, #UmojaBiopharma, has cleared another regulatory milestone after getting a #fasttrackdesignation from the FDA for its lead candidate for #bloodcancers, partnered with #AbbVie.

EVERSANA expands commercialisation portfolio with OS Therapies and Iterum Therapeutics partnerships

#EVERSANA #OSTherapies #IterumTherapeutics #OSTHER2 #paediatricosteosarcoma #immunotherapy #OrphanDesignation #FastTrackDesignation #RarePediatricDiseaseDesignation #BLAsubmission #EVERSANAONCOLOGY #ORLYNVAH #ProductCommercializationAgreement #oralpenemantibiotic
pharmaphorum.com/market-acces...

Argenx presents new efgartigimod data at EULAR 2025 - PharmaTimes Rheumatology studies show promising results for Sjogren’s disease

#pharmaceuticals #Rheumatology #NeuromuscularDisease #Argenx #efgartigimod #efgartigimoddata #EULAR2025 #Sjogrensdisease #myositis #FastTrackdesignation #primarySjogrensdisease #ALKIVIAstudy #myositispatients #FcRninhibitor #UNITYtrial
pharmatimes.com/news/argenx-...

Corbus Pharmaceuticals' CRB-701 Gains Fast Track Designation for Metastatic Cervical Cancer Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) has announced that its investigational drug CRB-701 has received Fast Track designation from the U.

www.linkedin.com/pulse/corbus...

Corbus Pharmaceuticals' CRB-701 Gains Fast Track Designation for Metastatic Cervical Cancer

kstrategyand.com/pharma-news

#CRB701 #FastTrackDesignation #CervicalCancer #Oncology #FDAApproval #CancerCare #Humanteconomy #Humantech #KStrategyand

Breakthrough for Lantern: LP-184 Gains Fast Track Designation for Aggressive Breast Cancer Lantern Pharma Inc., a pioneering artificial intelligence (AI)-driven biopharmaceutical company focused on revolutionizing cancer drug discovery, has announced that its investigational drug candidate,...

www.linkedin.com/pulse/breakt...

Breakthrough for Lantern: LP-184 Gains Fast Track Designation for Aggressive Breast Cancer

kstrategyand.com/pharma-news

#CancerResearch #FDA #TNBC #FastTrackDesignation #Oncology #NewTherapies #ClinicalTrials #Humanteconomy #Humantech #KStrategyand

Nurix Therapeutics has Received FDA’s Fast Track Designation for NX-5948 in Waldenstrom’s Macroglobulinemia - OncoDaily Nurix Therapeutics has Received FDA’s Fast Track Designation for NX-5948 in Waldenstrom’s Macroglobulinemia / Arthur T. Sands, cancer, EMA PRIME Designation,

Nurix Therapeutics has Received FDA’s Fast Track Designation for NX-5948 in Waldenstrom’s Macroglobulinemia

oncodaily.com/drugs/nurix-...

#Cancer #EMA #PRIMEDesignation #FDA #Medicine #FastTrackDesignation #NurixTherapeutics #OncoDaily #Oncology #Health